HKD 2.98
(1.02%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.71 Billion HKD | 14.4% |
2022 | 1.49 Billion HKD | 6.0% |
2021 | 1.41 Billion HKD | 43.51% |
2020 | 984.61 Million HKD | 12.3% |
2019 | 876.81 Million HKD | 48.0% |
2018 | 592.44 Million HKD | -44.18% |
2017 | 1.06 Billion HKD | -5.3% |
2016 | 1.12 Billion HKD | -23.97% |
2015 | 1.47 Billion HKD | 169.64% |
2014 | 546.7 Million HKD | -35.75% |
2013 | 850.86 Million HKD | 104.18% |
2012 | 416.72 Million HKD | 162.69% |
2011 | 158.63 Million HKD | 195.7% |
2010 | -165.76 Million HKD | -54.02% |
2009 | -107.62 Million HKD | -121.39% |
2008 | 503.08 Million HKD | 17.04% |
2007 | 429.82 Million HKD | 687.89% |
2006 | 54.55 Million HKD | 139.0% |
2005 | -139.88 Million HKD | -1190.37% |
2004 | 12.82 Million HKD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 2.04 Billion HKD | 0.0% |
2023 FY | 1.71 Billion HKD | 14.4% |
2023 Q4 | 1.71 Billion HKD | 0.0% |
2023 Q2 | 1.51 Billion HKD | 0.0% |
2022 Q4 | 1.49 Billion HKD | 0.0% |
2022 FY | 1.49 Billion HKD | 6.0% |
2022 Q2 | 1.6 Billion HKD | 0.0% |
2021 FY | 1.41 Billion HKD | 43.51% |
2021 Q4 | 1.41 Billion HKD | 0.0% |
2021 Q2 | 1.08 Billion HKD | 0.0% |
2020 Q2 | 1.05 Billion HKD | 0.0% |
2020 FY | 984.61 Million HKD | 12.3% |
2020 Q4 | 984.61 Million HKD | 0.0% |
2019 Q2 | 788.64 Million HKD | 0.0% |
2019 Q4 | 876.81 Million HKD | 0.0% |
2019 FY | 876.81 Million HKD | 48.0% |
2018 Q4 | 592.44 Million HKD | 0.0% |
2018 FY | 592.44 Million HKD | -44.18% |
2018 Q2 | 353.54 Million HKD | 0.0% |
2017 Q4 | 1.06 Billion HKD | 0.0% |
2017 FY | 1.06 Billion HKD | -5.3% |
2017 Q2 | 1.17 Billion HKD | 0.0% |
2016 Q4 | 1.12 Billion HKD | 0.0% |
2016 FY | 1.12 Billion HKD | -23.97% |
2016 Q2 | 1.39 Billion HKD | 0.0% |
2015 FY | 1.47 Billion HKD | 169.64% |
2015 Q4 | 1.47 Billion HKD | 0.0% |
2015 Q2 | 835.47 Million HKD | 0.0% |
2014 Q2 | 962.89 Million HKD | 0.0% |
2014 Q4 | 546.7 Million HKD | 0.0% |
2014 FY | 546.7 Million HKD | -35.75% |
2013 Q4 | 850.86 Million HKD | 0.0% |
2013 Q2 | 546.14 Million HKD | 0.0% |
2013 FY | 850.86 Million HKD | 104.18% |
2012 FY | 416.72 Million HKD | 162.69% |
2012 Q2 | 324.87 Million HKD | 0.0% |
2012 Q4 | 416.72 Million HKD | 0.0% |
2011 Q4 | 158.63 Million HKD | 0.0% |
2011 FY | 158.63 Million HKD | 195.7% |
2011 Q2 | 6.84 Million HKD | 0.0% |
2010 Q4 | -165.76 Million HKD | 0.0% |
2010 Q2 | -170.04 Million HKD | 0.0% |
2010 FY | -165.76 Million HKD | -54.02% |
2009 Q4 | -107.62 Million HKD | 0.0% |
2009 FY | -107.62 Million HKD | -121.39% |
2008 FY | 503.08 Million HKD | 17.04% |
2007 FY | 429.82 Million HKD | 687.89% |
2006 FY | 54.55 Million HKD | 139.0% |
2005 FY | -139.88 Million HKD | -1190.37% |
2004 FY | 12.82 Million HKD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Pak Fah Yeow International Limited | -258.7 Million HKD | 762.351% |
Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 15.667% |
Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | -28727.776% |
Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | -468.265% |
Qianhai Health Holdings Limited | -19.03 Million HKD | 9100.541% |
Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | -5436.781% |
Essex Bio-Technology Limited | -219.22 Million HKD | 881.613% |
Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | -568.916% |
PuraPharm Corporation Limited | 377.54 Million HKD | -353.854% |
JBM (Healthcare) Limited | -7.39 Million HKD | 23258.846% |
Jacobson Pharma Corporation Limited | 337.44 Million HKD | -407.798% |
China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 96.639% |